Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06140615
Other study ID # 2023-1132
Secondary ID 2023-026
Status Recruiting
Phase N/A
First received
Last updated
Start date December 11, 2023
Est. completion date June 2025

Study information

Verified date December 2023
Source University of Wisconsin, Madison
Contact Adam S Bauer, MD
Phone 608-417-6411
Email adam.bauer@wisc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to determine whether lung ultrasound can predict extubation success in neonates with respiratory distress. Participants will undergo a lung ultrasound pre- and post-extubation.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date June 2025
Est. primary completion date June 2025
Accepts healthy volunteers No
Gender All
Age group N/A to 6 Months
Eligibility Inclusion Criteria: - Infants born at UnityPoint Health Meriter Hospital and University of Minnesota admitted to the Neonatal Intensive Care Unit (NICU) with respiratory distress requiring intubation - Meeting the extubation readiness criteria per the attending neonatologist Exclusion Criteria: - Known major congenital disease (chromosomal abnormality, heart disease, respiratory malformation) - Neonates with parents that are less than 18 years old

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ultrasound
Ultrasound of lungs

Locations

Country Name City State
United States Unity-Point Health Meriter Madison Wisconsin
United States University of Minnesota Minneapolis Minnesota

Sponsors (2)

Lead Sponsor Collaborator
University of Wisconsin, Madison UnityPoint Health-Meriter

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ability of lung ultrasound score to predict extubation success Correlate the lung ultrasound score to the success of extubation, which is defined as remaining extubated for >72 hours. Ultrasound scores are measured on a 4-point scale (0=normal,3 = most abnormal). 12 hours pre-extubation to 24 hours post extubation
Secondary Change in pre- and post-extubation lung ultrasound scores Ultrasound scores are measured on a 4-point scale (0=normal,3 = most abnormal). 12 hours pre-extubation to 24 hours post extubation
Secondary Time to re-intubation Length of time from extubation to re-intubation. Up to 72 hours post-intubation
Secondary Change in heart rate Measure of heart rate before and after ultrasound procedure 5 minutes before to 5 minutes after lung ultrasound
Secondary Change in respiratory rate Measure of respiratory rate before and after ultrasound procedure 5 minutes before to 5 minutes after lung ultrasound
Secondary Change in oxygen saturation Measure of oxygen saturation before and after ultrasound procedure 5 minutes before to 5 minutes after lung ultrasound
See also
  Status Clinical Trial Phase
Completed NCT03347136 - Comparison of Continuous Positive Airway Pressure and Non Invasive Positive Pressure Ventilation N/A
Recruiting NCT05841121 - Antenatal Dexamethasone for Late Preterm Deliveries Phase 1